Turn Therapeutics Inc.
TTRX
$13.75
$1.098.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 638.70K | 477.60K | 496.90K | -- | -- |
| Gross Profit | -638.70K | -477.60K | -496.90K | -- | -- |
| SG&A Expenses | 1.15M | 1.14M | 2.16M | 1.75M | 1.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.27M | 1.72M | 2.69M | 1.91M | 1.37M |
| Operating Income | -2.27M | -1.72M | -2.69M | -1.91M | -1.37M |
| Income Before Tax | -5.85M | -971.00K | 279.10K | -1.90M | -1.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.85M | -971.00K | 279.10K | -1.90M | -1.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.85M | -971.00K | 279.10K | -1.90M | -1.24M |
| EBIT | -2.27M | -1.72M | -2.69M | -1.91M | -1.37M |
| EBITDA | -2.25M | -1.71M | -2.68M | -1.90M | -1.35M |
| EPS Basic | -0.20 | -0.03 | 0.01 | -0.07 | -0.05 |
| Normalized Basic EPS | -0.12 | -0.02 | 0.01 | -0.04 | -0.03 |
| EPS Diluted | -0.20 | -0.03 | 0.01 | -0.07 | -0.05 |
| Normalized Diluted EPS | -0.12 | -0.02 | 0.01 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 29.79M | 29.48M | 28.43M | 27.98M | 27.49M |
| Average Diluted Shares Outstanding | 29.79M | 29.48M | 28.43M | 27.98M | 27.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |